Evaluation of synthetic/reconstituted high-density lipoproteins as delivery vehicles for paclitaxel

Counsell, 1982, Lipoproteins as potential site-specific delivery systems for diagnostic and therapeutic agents, J Med Chem, 10, 1115, 10.1021/jm00352a001

Kader, 2002, Loading anticancer drugs into HDL as well as LDL has little effect on properties of complexes and enhances cytotoxicity to human carcinoma cells, J Control Release, 80, 29, 10.1016/S0168-3659(01)00536-3

Firestone, 1984, Selective delivery of cytotoxic compounds to cells by the LDL pathway, J Med Chem, 27, 1037, 10.1021/jm00374a017

Lacko, 2002, High density lipoprotein complexes as delivery vehicles for anticancer drugs, Anticancer Res, 22, 2045

Lacko, 2007, Nanotechnology in cancer therapy, 777

Lacko, 2006, Trojan horse meets magic bullet to spawn a novel, highly effective drug delivery model, Chemotherapy, 52, 171, 10.1159/000093268

Brewer, 1986, Isolation and characterization of apolipoprotein A-I, A-II and A-IV, Methods Enzymol, 128, 223, 10.1016/0076-6879(86)28070-2

Matz, 1982, Micellar complexes of human apolipoprotein A-I with phosphatidylcholines and cholesterol prepared from cholate-lipid dispersion, J Biol Chem, 257, 4535, 10.1016/S0021-9258(18)34756-2

Jonas, 1986, Reconstitution of high density lipoproteins, Methods Enzymol, 128, 553, 10.1016/0076-6879(86)28092-1

Kelley, 1986, Density gradient ultracentrifugation of serum lipoproteins in a swinging bucket rotor, Methods Enzymol, 128, 170, 10.1016/0076-6879(86)28067-2

Terpstra, 1981, Improved techniques for the separation of serum lipoproteins by density gradient ultracentrifugation, Anal Biochem, 111, 49, 10.1016/0003-2697(81)90243-8

Loney, 1997, Evaluation of gemfibrozil therapy: predictive response from lipoprotein subfraction analysis, Am J Ther, 9–10, 301, 10.1097/00045391-199709000-00004

Forte, 1971, Plasma lipoproteins in familial lecithin: cholesterol acyltransferase deficiency: structure of low and high density lipoproteins as revealed by electron microscopy, J Clin Invest, 50, 1141, 10.1172/JCI106586

Arnould, 1990, Comparison of two cytotoxicity assays – tetrazolium derivative reduction (MTT) and tritiated thymidine uptake – on three malignant mouse cell lines using chemotherapeutic agents and investigational drugs, Anticancer Res, 10, 145

Urrutia-Rojas, 2004, Cardiovascular risk factors in Mexican Americans at risk for type 2 diabetes mellitus, J Adolescent Health, 34, 290, 10.1016/j.jadohealth.2003.07.005

Kieft, 1991, Rapid online determination of cholesterol among plasma lipoproteins after high performance gel filtration chromatography, J Lipid Res, 32, 859, 10.1016/S0022-2275(20)42037-1

Ackers, 1970, Analytical gel chromatography of proteins, Adv Protein Chem, 24, 343, 10.1016/S0065-3233(08)60245-4

Gal, 1981, Low-density lipoprotein as a potential vehicle for chemotherapeutic agents and radionucleotides in the management of gynecologic neoplasms, Am J Obstet Gynecol, 139, 877, 10.1016/0002-9378(81)90952-2

Peterson, 1991, Lipoproteins, malignancy, and anticancer agents, Targeted Diagn Ther, 5, 175

Lundberg, 1987, Preparation of drug-low density lipoprotein complexes for delivery of antitumoral drugs via the low density lipoprotein pathway, Cancer Res, 47, 4105

Cao, 2004, Mutant high-density lipoprotein receptor inhibits proliferation of human breast cancer cells, Cancer Res, 64, 1515, 10.1158/0008-5472.CAN-03-0675

Markel, 2004, Cancer and hypocholesterolemia, Isr J Med Sci, 30, 787

Vitols, 1990, Uptake of low density lipoproteins by human leukemic cells in vivo: relation to plasma lipoprotein levels and possible relevance for selective chemotherapy, Proc Natl Acad Sci U S A, 87, 2598, 10.1073/pnas.87.7.2598

Goncalves, 2005, Uptake of high density lipoprotein (HDL) cholesteryl esters by human acute leukemia cells, Leuk Res, 29, 955, 10.1016/j.leukres.2005.01.013

Zheng, 2005, Rerouting lipoprotein nanoparticles to selected alternate receptors for the targeted delivery of cancer diagnostic and therapeutic agents, Proc Natl Acad Sci U S A, 102, 17757, 10.1073/pnas.0508677102

Ryan, 2003, Optimized bacterial expression of human apolipoprotein A-I, Protein Expr Purif, 27, 98, 10.1016/S1046-5928(02)00568-5

Baillie, 2002, A synthetic low density lipoprotein particle capable of supporting U937 proliferation in vitro, J Lipid Res, 43, 69, 10.1016/S0022-2275(20)30188-7

Owens, 2001, Physicochemical properties of microemulsion analogues of low density lipoprotein containing amphiphatic apoprotein B receptor sequences, Int J Pharm, 228, 109, 10.1016/S0378-5173(01)00818-3

Nikanjam, 2007, Synthetic nano-low density lipoprotein as targeted drug delivery vehicle for glioblastoma multiforme, Int J Pharm, 328, 86, 10.1016/j.ijpharm.2006.07.046